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To estimate the global illness and deaths caused by
rotavirus disease, we reviewed studies published from
1986 to 2000 on deaths caused by diarrhea and on
rotavirus infections in children. We assessed rotavirus-
associated illness in three clinical settings (mild cases
requiring home care alone, moderate cases requiring a
clinic visit, and severe cases requiring hospitalization) and
death rates in countries in different World Bank income
groups. Each year, rotavirus causes approximately 111 mil-
lion episodes of gastroenteritis requiring only home care,
25 million clinic visits, 2 million hospitalizations, and
352,000–592,000 deaths (median, 440,000 deaths) in chil-
dren <5 years of age. By age 5, nearly every child will have
an episode of rotavirus gastroenteritis, 1 in 5 will visit a
clinic, 1 in 65 will be hospitalized, and approximately 1 in
293 will die. Children in the poorest countries account for
82% of rotavirus deaths. The tremendous incidence of
rotavirus disease underscores the urgent need for interven-
tions, such as vaccines, particularly to prevent childhood
deaths in developing nations.
I
n 1985, de Zoysa and Feachem published their landmark
review of the global prevalence of rotavirus disease (1).
Their analyses indicated that rotavirus accounted for 6% of
diarrhea episodes and 20% of deaths caused by diarrhea in
children <5 years of age in developing countries. The inci-
dence of rotavirus disease was observed to be similar in
both industrialized and developing countries, suggesting
that adequate control may not be achieved by improve-
ments in water supply, hygiene, and sanitation.
Consequently, the development, trial, and widespread use
of rotavirus vaccines were recommended to prevent severe
and fatal rotavirus disease.
Since then, rapid progress has been made in developing
and testing several rotavirus vaccine candidates (2,3). In
August 1998, a live, attenuated rotavirus vaccine
(Rotashield, Wyeth Laboratories, Marietta, PA) was
licensed in the United States and recommended for routine
immunization of U.S. infants. However, 9 months later, the
use of Rotashield was suspended because reports suggest-
ed a possible association with intussusception (4). After
this association was confirmed, the recommendation for
use of Rotashield was withdrawn and the manufacturer
stopped vaccine production.
Efforts are ongoing to develop other rotavirus vaccines,
and several candidates are undergoing clinical testing (3).
In addition to their safety and efficacy, the decision to
implement these new rotavirus vaccines will be based on
considerations of risk-benefit and cost-effectiveness.
Updated estimates of rotavirus disease prevalence are a
prerequisite to formulating such policy and carrying out
economic analyses as well as advocacy for the next gener-
ation of rotavirus vaccines. Furthermore, each country that
considers using a rotavirus vaccine may want to review the
prevalence of rotavirus disease in their setting.
Since 1985, deaths from diarrheal diseases in children
have declined substantially around the world, and a recent
analysis suggested that deaths from rotavirus infections
might also have been reduced during this period (5,6).
Furthermore, scant information is available on the global
extent of illness from rotavirus disease, particularly hospi-
talizations, which constitute a major component of total
rotavirus health costs in industrialized nations. To provide
updated estimates of the global illness and death from
rotavirus disease in children, we reviewed studies of child-
hood deaths from diarrhea and of rotavirus infections pub-
lished from 1986 to 2000. We also present preliminary
estimates of country-specific mortality rates from rotavirus
disease as targets for further study and refinement through
local definition of problems. These findings should help
policy makers assess the magnitude of the problem of
rotavirus disease in their own countries and set priorities
for interventions to prevent this disease.
Methods
Selection of Studies
The studies selected for this analysis were identified
from a computer search of the scientific literature pub-
lished in English between 1986 and 2000. To find studies
of childhood deaths from diarrhea, we conducted a search
using the keywords “childhood mortality,” “deaths,” and
“diarrhea.” We added references by reviewing the citations
in these articles and by consulting with experts in the field.
Because most studies of diarrhea deaths were conducted in
countries with a low-income population, we supplemented
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To identify studies of rotavirus disease, we conducted a
search using the keyword “rotavirus” and cross-linked the
articles with a second set of articles obtained from a sec-
ondary search using these keywords: incidence, prevalence,
public health, death rate, mortality, surveillance, burden,
suffering, distribution, area, location, and country. We also
searched for permutations of these root words: epidemiol,
monitor, and geograph. We then reviewed the resulting
linked set of articles and narrowed it down to articles with
content that was relevant to the goals of this study. We iden-
tified additional citations from references in these articles.
Studies of rotavirus were included if they continued for at
least 1 year, contained data on children <5 years of age, and
reported using an enzyme immunoassay (EIA) or similar
reliable assay to detect rotavirus. A listing of the studies
included in the analyses is available in Appendix A (online




To estimate the extent of illness from rotavirus in chil-
dren in developing countries, we first multiplied the total
population of infants (0–11 months) and children (12–59
months) in those countries by the estimated annual inci-
dence of diarrhea in the respective age groups (5,7). On the
basis of published estimates from a study in Chile (8), we
then distributed these diarrhea episodes into three settings:
mild cases only requiring care at home; moderate cases
requiring care in an outpatient clinic; and severe cases
requiring hospitalization. Next, on the basis of studies we
reviewed, we calculated the median proportion of diarrhea
episodes attributable to rotavirus in each of the three set-
tings. Finally, we multiplied the total number of diarrhea
episodes in each setting by the estimated proportion attrib-
utable to rotavirus to yield the number of rotavirus cases in
each setting.
To estimate the number of hospitalizations for rotavirus
among children in industrialized countries, we multiplied
estimates of the total population of children <5 years of age
with rotavirus-associated hospitalization rates derived from
published studies. To calculate clinic visits and episodes of
rotavirus disease, we evaluated studies documenting the
frequency of these outcomes relative to hospitalizations
and multiplied the calculated total number of rotavirus-
associated hospitalizations by corresponding factors. The
figures thus obtained were combined with estimates of
rotavirus illness in children in developing countries to yield
the global extent of illness from rotavirus disease.
Rotavirus-Associated Deaths
To estimate the total number of child deaths from diar-
rhea, we plotted (for each country with available data) the
fraction of deaths of children <5 years of age attributable
to diarrhea against per capita gross national product
(GNP). Countries were classified on the basis of GNP per
capita into World Bank Income Groups (low [<U.S.$756],
low-middle [U.S.$756–$2,995], high-middle [U.S.
$2,996–$9,265], high [>U.S. $9,265]) (9). For each
income group, we calculated the median proportion of
deaths of children <5 years of age attributable to diarrhea.
We then multiplied the median proportion for each
income group by the total number of deaths of children <5
years of age for each country in that income group to yield
country-specific estimates of the mortality rate from diar-
rhea. These country-specific estimates were added to cal-
culate the global mortality rate from diarrhea.
To estimate the fraction of diarrhea deaths attributable
to rotavirus, we plotted the proportion of rotavirus infec-
tion detected in children hospitalized for diarrhea that was,
by virtue of the need for hospitalization, presumed to be
severe. These figures were again plotted against per capita
GNP for each country to yield median rotavirus detection
rates for countries in the four World Bank income groups.
Previously estimated diarrhea mortality rates for each
country in an income group was multiplied by the median
rotavirus detection rate for that income group to yield the
estimated number of rotavirus deaths by country. These
figures were added to yield the number of global deaths
from rotavirus diarrhea. For each income strata and over-
all, the risk of death from rotavirus diarrhea by 5 years of
age was calculated by dividing the total number of live
births by the total number of deaths from rotavirus.
Results
Rotavirus Disease in Children in Developing
Countries
Total Number of Diarrhea Episodes
An estimated 125 million infants 0–11 months of age
and 450 million children 1–4 years of age reside in devel-
oping countries. A recent review of 27 prospective studies
from 20 countries published from 1990 to 2000 estimated
the incidence of diarrhea as 3.8 episodes per child per year
for children <11 months of age and 2.1 episodes per child
per year for children 1–4 years of age (5). Multiplying
these age-specific incidence data with the population of
children in each age group yielded an overall estimate of
approximately 1.4 billion diarrhea episodes per year in
children <5 years of age (Table 1). Of these, 475 million
episodes are estimated to occur in <11-month-old infants
and 945 million episodes in children 1–4 years of age.
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Astudy from Chile demonstrated that in <11-month-old
infants, 88.2% of diarrhea episodes required only care at
home, 10.3% required a clinic visit, and 1.5% required
hospitalization (8). In 1- to 4-year-old children, 91.9% of
diarrhea episodes required only care at home, 7.9%
required a clinic visit, and only 0.2% required hospitaliza-
tion. The proportion of all diarrhea episodes requiring hos-
pitalization was similar in another study from Thailand
(10). Therefore, we applied the estimates from the Chilean
study to the previously calculated total number of diarrhea
episodes in each age group and distributed them into
episodes requiring only home care, clinic visit, or hospital-
ization (Table 1). Of the total of approximately 1.4 billion
diarrhea episodes in children <5 years of age, we estimat-
ed that 1.29 billion require home care only, 124 million
require a clinic visit, and 9 million require hospitalization.
Number of Rotavirus Episodes in Each Setting
To estimate the number of diarrhea cases in each setting
that are attributable to rotavirus, we applied proportions
calculated from studies of rotavirus in children in develop-
ing countries. The review of 24 community-based studies,
13 clinic-based studies, and 72 hospital-based studies indi-
cated that rotavirus accounted for a median of 8.1%,
18.8%, and 21.3% of diarrhea episodes in the three set-
tings, respectively (Table 2). By multiplying these setting-
specific proportions with the total number of diarrhea
episodes in each setting, we calculated that rotavirus annu-
ally causes approximately 104 million episodes of diarrhea
requiring home care, 23 million clinic visits, and 1.9 mil-
lion hospitalizations.
Illness from Rotavirus Disease in Children in
Industrialized Countries
Hospitalizations
Examination of rotavirus-specific annual hospitaliza-
tion incidence from several industrialized countries
demonstrated a median rate of 445 per 100,000 children
(interquartile range, 283–715 per 100,000) (11–20) (Table
3). By multiplying these incidence estimates with the total
population of 50,016,000 children <5 years of age in
industrialized nations, we estimated that a total of 223,000
(range 142,000–358,000) rotavirus-associated hospitaliza-
tions occur in children in industrialized nations.
Clinic Visits
No reliable estimates of rotavirus-associated clinic visit
rates are available for children in industrialized countries.
However, studies have shown that for each child hospital-
ized with rotavirus diarrhea, approximately 5–10 children
require a visit to a healthcare facility or physician’s office
(17,21,22). Therefore, we multiplied the estimated
223,000 rotavirus hospitalizations by a factor of 8 (range
5–10) to obtain an estimated total of approximately
1,781,000 (range 708,000–3,576,000) clinic visits for
rotavirus disease in children <5 years of age.
Episodes Requiring Only Home Care
Studies have estimated that for each child requiring
medical attention for rotavirus disease, an additional three
to five children develop symptomatic disease requiring
only home-care (21,22). Therefore, we multiplied the esti-
mated 1,781,000 clinic visits by a factor of 4 (range 3–5)
to estimate a total number of 7,122,000 (range
2,123,000–17,881,000) episodes of rotavirus gastroenteri-
tis requiring only home care in children <5 years of age.
Overall Illness from Rotavirus 
Gastroenteritis Worldwide
By adding the total prevalence of rotavirus illness in
children in developing and industrialized nations, we esti-
mated that each year rotavirus causes approximately 111
million episodes of gastroenteritis that require home care
only, 25 million clinic visits, and 2 million hospitalizations
in children <5 years of age worldwide (Table 4).
Deaths from Rotavirus Disease in Children 
<5 Years of Age Worldwide
The proportion of deaths in children <5 years of age
attributable to diarrhea demonstrated a declining trend
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Table 1. Estimates of the annual number of diarrhea episodes among children <5 years of age in developing countries, by age group 
and setting
a 
  Age group 
  <11 mo  1–4 y  Total (<4 y) 
Total population (x1,000)  125,000  450,000  575,000 
No. of diarrhea episodes per child per y
b  3.8  2.1  NA 
Total diarrhea episodes (x1,000)  475,000  945,000  1,420,000 
    No. of episodes at home (x1,000)  418,950 (88.2)  868,455 (91.9)  1,287,405 
    No. of episodes in outpatients (x1,000)  48,925 (10.3)  74,655 (7.9)  123,580 
    No. of case-patients hospitalized (x1,000)  7,125 (1.5)  1,890 (0.2)  9,015 
aFigures in parenthesis are percentages of total diarrhea episodes (7). 
bFrom reference (5). with increasing income level (Figure 1A); the median pro-
portion for low-income countries was 21%; for low-mid-
dle income countries, 17%; for high-middle income coun-
tries, 9%; and for high-income countries, 1%. We multi-
plied these income stratum-specific median estimates with
the combined <5 mortality estimates for countries in each
of the four income strata to yield an overall estimate of 2.1
million (range 1.7 million–3.0 million) diarrhea deaths per
year (Table 5). Of the median 2.1 million diarrhea deaths,
85% (N=1,805,000) occurred in children from low-income
countries.
The proportion of diarrhea hospitalizations attributable
to rotavirus demonstrated an increasing trend with increas-
ing income level (Figure 1B); the median for low-income
countries was 20%; for low-middle income countries,
25%; for high-middle income countries, 31%; and for
high-income countries, 34%. We multiplied these stratum-
specific proportions with the median estimate of total diar-
rhea deaths for countries in each of the four income strata
to yield an estimated 352,000–592,000 (median 440,000
deaths) per year from rotavirus. Of the median 440,000
deaths, 82% (N=361,000) occurred in children from low-
income countries.
To obtain country-specific estimates of deaths from
diarrhea and rotavirus disease, we first multiplied United
Nations Children’s Fund estimates of total number of
deaths of children <5 years of age for each country in each
income stratum with the median proportion for that stra-
tum of deaths in children <5 years of age attributable to
diarrhea. The obtained country-specific estimates of diar-
rhea deaths were further multiplied by the median propor-
tion for that stratum of diarrhea hospitalizations attributa-
ble to rotavirus. The results of these calculations are pre-
sented in the Appendix B (online only; available from:
URL: http://www.cdc.gov/ncidod/EID/vol9no5/02-0562_
appB.htm) and shown in Figure 2.
Discussion
The findings of this study demonstrate the tremendous
amount of global illness and deaths caused by rotavirus
disease. Each year, rotavirus causes an estimated 111 mil-
lion episodes of diarrhea requiring only home care, 25 mil-
lion clinic visits, 2 million hospitalizations, and
352,000–592,000 deaths (median 440,000 deaths) in chil-
dren <5 years of age. In other words, by 5 years of age,
almost all children will have an episode of rotavirus gas-
troenteritis, 1 in 5 will require a clinic visit, 1 in 65 will
require hospitalization, and approximately 1 in 293 will
die (Figure 3). The incidence of rotavirus disease is simi-
lar in children in both developed and developing nations.
However, children in developing nations die more fre-
quently, possibly because of several factors, including
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Table 2. Estimates of the annual number of episodes of rotavirus diarrhea among children <5 years of age in developing countries, by 
setting 
  Home  Outpatient  Inpatient 
Annual no. of diarrhea episodes (x1,000)  1,287,405  123,580  9,015 
Median % of episodes with rotavirus (IQR)
a  8.1 (4.0–12.2)  18.8 (15.0–22.0)  21.3 (17.2–28.8) 
Total rotavirus episodes (range) (x1,000)  104,280 (51,496–157,063)  23,233 (18,537–27,188)  1,920 (1,551–2,596) 
aIQR, interquartile range. 
Table 3. Annual incidence of hospitalizations for rotavirus gastroenteritis in children <5 years of age in selected industrialized countries 
Country (reference)  Y  Annual incidence/100,000 children  Cumulative incidence by 5 y of age 
Spain (11)  1989–1995  250  1 in 80 
Netherlands (12)  1998  270  1 in 74 
United States (13)  1993–1995  274  1 in 73 
Poland (14)  1996  310  1 in 65 
Sweden (15)  1993–1996  370
a  1 in 54 
United Kingdom (16)  1993–1994  520  1 in 38 
Finland (17)  1985–1995  610  1 in 33 
Australia (18)  1993–1996  750  1 in 27 
Hungary (19)  1993–1996  840
a  1 in 24 
Australia (20)  1991–1993  870  1 in 23 
aIncidence for children <4 years of age. 
Table 4. Annual global illness incidence from rotavirus disease among children <5 years age, by setting 
  No. (range) of episodes of rotavirus disease (x1,000) 
Setting  Developing countries  Industrialized countries  Total 
Home  104,280 (51,496–157,063)  7,122 (2,123–17,881)  111,402 (53,619–174,946) 
Outpatient  23,233 (18,537–27,188)  1,781 (708–3,576)  25,017 (19,245–30,764) 
Inpatient  1,920 (1,551–2,596)  223 (142–358)  2,143 (1,693–2,954) poorer access to hydration therapy and a greater preva-
lence of malnutrition. An estimated 1,205 children die
from rotavirus disease each day, and 82% of these deaths
occur in children in the poorest countries.
In 1986, the Institute of Medicine (IOM) estimated, on
the basis of published studies and field experience, that
annually rotavirus causes approximately 110 million
episodes of mild diarrhea, 10 million episodes of moderate
to severe diarrhea, and 9 million episodes of severe diar-
rhea in children <5 years of age worldwide (23). Our esti-
mate of the incidence of rotavirus gastroenteritis is similar
to the IOM estimate and is consistent with a recent analy-
sis demonstrating that overall diarrhea illness in children
worldwide has not declined appreciably in the past two
decades (5). However, our estimate of total hospitaliza-
tions from rotavirus disease is substantially lower than the
IOM estimate. The difference might be explained, in part,
by the relatively low hospitalization rate for diarrhea in the
study in Chile (1.5% of all diarrhea episodes) used in our
calculations (8). However, a study in a low-income urban
community in Thailand showed a similar hospitalization
rate (1% of all diarrhea episodes) among children with
diarrhea (10), giving us added confidence in our estimates.
Increased use of oral rehydration therapy and improve-
ments in nutritional status are two factors that might
explain a possible reduction in severe rotavirus cases with-
out a concomitant decline in diarrhea incidence (24,25).
Our estimate of 352,000–592,000 deaths (median:
440,000 deaths) from rotavirus disease each year is similar
to a recent estimate of 418,000–520,000 deaths proposed
by Miller and McCann (6) but is substantially lower than
the 1985 IOM estimate of 873,000 deaths. This decline in
the rotavirus mortality rate parallels the decline in overall
deaths from diarrhea in children in the past two decades,
from an estimated 4.6 million deaths in 1982 (26) to our
estimate of 2.1 million deaths in 2000. However, the pat-
terns of diarrhea deaths reported in this study reflect the
situation a decade ago, when most studies that we
reviewed were conducted. Analyses of vital registration
data from several countries have suggested that the propor-
tion of deaths from diarrhea may have declined further in
recent years (27). Other studies have noted marked dis-
crepancies in the analysis of cause of death from vital reg-
istration data and prospective observational studies (28).
Careful and detailed analyses are required to assess the
current magnitude of the deaths from diarrhea in children,
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Figure 1. A. Percentage of deaths in children <5 years that are attributable to diarrhea for countries in different World Bank income
groups, by gross national product (GNP) per capita of the country. B. Percentage of diarrhea hospitalization attributable to rotavirus for
countries in different World Bank income groups, by GNP per capita of the country. IQR, interquartile range.
Table 5. Global estimates of the annual number of diarrhea and rotavirus deaths among children <5 years of age, by income group 
Total no. (x1,000)  Diarrhea deaths  Rotavirus deaths
b 
Income 
group  Births  Deaths 
Median % (IQR
a) 
of total deaths 
Median no. (IQR) of 
deaths (x1,000) 
Median % (IQR) of 
diarrhea hospitalizations 
Median no. (IQR) of 
deaths (x1,000) 
Risk of dying from 
rotavirus by age 5 
Low  70,447  8,595  21 (17–30)  1,805 (1,461–2,579)  20 (16–27)  361 (289–487)  1 in 205 
Low middle  37,402  1,609  17 (11–23)  274 (177–370)  25 (20–33)  69 (55–90)  1 in 542 
Upper 
middle 
11,520  366  9 (5–17)  33 (18–62)  31 (25–42)  10 (8–14)  1 in 1,152 
High  9,931  60  1  <1  34 (28–38)  <1  1 in 48,680 
Total  129,300  10,630  NA  2,112 (1,657–3,012)  NA  440 (352–592)  1 in 293 
aIQR, interquartile range; NA, not applicable. 
bThe estimated number and range of deaths from rotavirus are derived by multiplying the median and IQR of diarrhea hospitalizations attributable to rotavirus by the 
median number of deaths caused by diarrhea for each stratum 
A Band the results will directly affect our estimates of deaths
from rotavirus disease. For example, if our estimated pro-
portion of severe diarrhea cases attributable to rotavirus is
applied to the recent estimate of 2.5 million annual diar-
rhea deaths developed by Kosek et al. (5), we estimate
416,000–700,000 annual deaths (median:520,000 deaths)
from rotavirus disease.
Another important factor that could affect our estimate
of rotavirus deaths is the possibility that as the overall mor-
tality rate from diarrhea has declined over the past two
decades, the proportion of diarrhea deaths attributable to
rotavirus may have increased, given that this pathogen is
often transmitted from person to person and is difficult to
control through improvements in hygiene and sanitation.
This hypothesis is supported by data from Mexico, demon-
strating that whereas deaths from diarrhea declined sub-
stantially from 1989 to 1995, the decline was less evident
for winter seasonal deaths in children <2 years of age
whose illness met the epidemiologic features of rotavirus
diarrhea (29). In addition, some recent studies of rotavirus
based on hospital surveillance in developing countries
have demonstrated detection rates in excess of 50%
(30,31). If this trend is confirmed as additional data
become available from ongoing surveillance studies in
several regions of the world, the estimates of rotavirus
deaths reported in this article will have to be revised to
reflect current mortality patterns.
This review, based on a compilation of studies varying
in design, time, and place, has several inherent limitations
that we attempted to address. Because of the marked sea-
sonality of rotavirus disease and the variation in the sensi-
tivity and specificity of diagnostic tests for rotavirus, we
restricted this review to studies that lasted at least 1 year
and used reliable assays for the detection of rotavirus. To
account for known temporal changes in the magnitude and
patterns of diarrhea-associated childhood deaths, we
reviewed only studies published within the last 15 years
and used the most recent available estimates of total deaths
in children <5 years to calculate estimates of diarrhea
deaths. Furthermore, because regional boundaries are pri-
marily based on geographic and political considerations
and do not necessarily reflect important determinants of
health, we used indicators of socioeconomic status to strat-
ify our analyses of mortality patterns. 
Nevertheless, we could not adequately account for sev-
eral factors that may have affected our findings. First, the
studies we reviewed were conducted in selective popula-
tions that may not have been representative of the entire
country. Second, most diarrhea mortality studies used ver-
bal autopsies to determine the cause of death, which may
affect our estimates because these methods have variable
sensitivity and specificity and it is difficult, if not impossi-
ble, to assign a single cause of death for children who died
with multiple conditions (32–34). Finally, because of a
time lag between the conduct of studies and publication of
their findings, our data likely do not reflect the most cur-
rent trends of diarrhea and rotavirus disease patterns.
In 1998, the first rotavirus vaccine was licensed in the
United States, offering an encouraging opportunity for the
prevention of this disease. However, the vaccine was with-
drawn within a year of licensure because it caused an esti-
mated one case of intussusception for every 12,000 vacci-
nated infants. The lack of sufficient data on the efficacy of
vaccine in developing countries as well as political and
ethical considerations diminished prospects for its use in
these settings. Our findings demonstrate that the next gen-
eration of rotavirus vaccines will have greatest impact in
developing countries where the disease burden is greatest.
Our estimates of rotavirus mortality rates for individual
countries, although developed with relatively crude meth-
ods, compare favorably with those from more detailed
analysis conducted in selected countries. For example,
good concordance was noted between the previous figures
and our estimates of rotavirus mortality for Bangladesh
(14,850–27,000 vs. 13,104 deaths) (35), Peru (1,600 vs.
1,360 deaths) (36), and India (98,000 vs. 100,800 deaths)
(37). The establishment of regional networks for rotavirus
surveillance in sentinel hospitals will facilitate more time-
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Figure 2. Estimated global distribution of 440,000 annual deaths in
children caused by rotavirus diarrhea. One dot=1,000 deaths
Figure 3. Estimated global prevalence of rotavirus disease.ly and refined estimates of disease illness and death. These
data, along with information on illness and costs of
rotavirus infections, will assist policy makers in assessing
the magnitude of the problem of rotavirus in their own set-
ting and in setting priorities for interventions, such as the
next generation of rotavirus vaccines, which may be avail-
able in the near future.
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